Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001564590-16-019740
Filing Date
2016-05-20
Accepted
2016-05-19 18:11:11
Documents
14

Document Format Files

Seq Description Document Type Size
1 S-3 cdtx-s3_20160519.htm S-3 1010452
2 EX-1.2 cdtx-ex12_425.htm EX-1 311824
3 EX-4.5 cdtx-ex45_85.htm EX-4 457952
4 EX-4.7 cdtx-ex47_84.htm EX-4 135264
5 EX-4.8 cdtx-ex48_83.htm EX-4 160621
6 EX-4.9 cdtx-ex49_82.htm EX-4 119745
7 EX-5.1 cdtx-ex51_389.htm EX-5 39766
8 EX-12.1 cdtx-ex121_81.htm EX-12 117574
9 EX-23.1 cdtx-ex231_128.htm EX-23 2673
10 GRAPHIC gv52lzvlny2i000001.jpg GRAPHIC 35247
11 GRAPHIC gv52lzvlny2i000002.jpg GRAPHIC 35247
12 GRAPHIC gv52lzvlny2i000003.jpg GRAPHIC 4807
13 GRAPHIC gv52lzvlny2i000004.jpg GRAPHIC 35247
14 GRAPHIC gv52lzvlny2i000005.jpg GRAPHIC 5671
  Complete submission text file 0001564590-16-019740.txt   2517751
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170
Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)

EIN.: 461537286 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-211472 | Film No.: 161664283
SIC: 2836 Biological Products, (No Diagnostic Substances)